Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica ; volume:15 ; number:1 ; day:22 ; month:10 ; year:2018 ; pages:1-11 ; date:12.2018
Journal of neuroinflammation ; 15, Heft 1 (22.10.2018), 1-11, 12.2018
- Creator
-
Duan, Tianjiao
- Contributor
-
Smith, Alex J.
Verkman, Alan S.
SpringerLink (Online service)
- DOI
-
10.1186/s12974-018-1333-z
- URN
-
urn:nbn:de:101:1-2018112523020597688609
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Duan, Tianjiao
- Smith, Alex J.
- Verkman, Alan S.
- SpringerLink (Online service)
Other Objects (12)
Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G
Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositive patients in a Chinese population
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G
Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositive patients in a Chinese population
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G
Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositive patients in a Chinese population
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
The history of neuromyelitis optica